NASDAQ:TMCI Treace Medical Concepts (TMCI) Stock Price, News & Analysis $4.39 0.00 (0.00%) Closing price 10/2/2026 04:00 PM EasternExtended Trading$4.50 +0.11 (+2.60%) As of 07:35 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Treace Medical Concepts Stock (NASDAQ:TMCI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get TMCI alerts:Sign Up Key Stats Today's Range$4.22▼$4.4150-Day Range$4.01▼$4.8852-Week Range$1.17▼$7.08Volume154,669 shsAverage Volume202,366 shsMarket Capitalization$285.53 millionP/E RatioN/ADividend YieldN/APrice Target$5.17Consensus RatingReduce Company Overview Treace Medical Concepts, Inc. is a medical technology company focused on advancing surgical treatment for bunions and other deformities of the big toe and forefoot. The company develops and commercializes medical devices, surgical instruments and procedure-based solutions designed to address the underlying structural causes of bunion deformities. Its flagship offering is the Lapiplasty 3D Bunion Correction System, which is intended to correct bunions in three dimensions and stabilize the affected joint. Treace also offers related products and technologies, including the Adductoplasty system for addressing associated metatarsal deformities and specialized plates, implants and instruments used in bunion-correction procedures. Founded in 2013, Treace markets its products primarily to orthopedic and podiatric surgeons and supports adoption through physician education, surgical training and procedural resources. The company is headquartered in Ponte Vedra Beach, Florida, and was founded by John T. Treace, who has served as its chairman and chief executive officer. Its products are primarily used in the United States, with the company working to expand access to its surgical solutions in additional markets.AI Generated. May Contain Errors. Read More Treace Medical Concepts Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks47th Percentile Overall ScoreTMCI MarketRank™: Treace Medical Concepts scored higher than 47% of companies evaluated by MarketBeat, and ranked 534th out of 888 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.7 / 5Analyst RatingReduce Consensus RatingTreace Medical Concepts has received a consensus rating of Reduce. The company's average rating score is 1.86, and is based on no strong buy ratings, 1 buy rating, 4 hold ratings, and 2 sell ratings.Upside PotentialTreace Medical Concepts has a consensus price target of $5.17, representing about 17.8% upside from its current price of $4.39.Amount of Analyst CoverageTreace Medical Concepts has only been the subject of 2 research reports in the past 90 days.Read more about Treace Medical Concepts' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Treace Medical Concepts are expected to grow in the coming year, from ($0.83) to ($0.81) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Treace Medical Concepts is -4.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Treace Medical Concepts is -4.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTreace Medical Concepts has a P/B Ratio of 3.20. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Treace Medical Concepts' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted3.49% of the float of Treace Medical Concepts has been sold short.Short Interest Ratio / Days to CoverTreace Medical Concepts has a short interest ratio ("days to cover") of 8.46.Change versus previous monthShort interest in Treace Medical Concepts has recently increased by 11.26%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldTreace Medical Concepts does not currently pay a dividend.Dividend GrowthTreace Medical Concepts does not have a long track record of dividend growth. News and Social Media1.5 / 5News Sentiment0.45 News SentimentTreace Medical Concepts has a news sentiment score of 0.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Treace Medical Concepts this week, compared to 2 articles on an average week. Company Ownership4.3 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $246,841.00 in company stock, which represents 0.0865% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, Treace Medical Concepts insiders have bought more of their company's stock than they have sold. Specifically, they have bought $246,841.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders23.42% of the stock of Treace Medical Concepts is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions84.08% of the stock of Treace Medical Concepts is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Treace Medical Concepts' insider trading history. Receive TMCI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Treace Medical Concepts and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TMCI Stock News HeadlinesTreace Medical Concepts, Inc. (NASDAQ:TMCI) Stock Has Consensus Target Price of $5.17 According to AnalystsSeptember 30, 2026 | americanbankingnews.comCritical Comparison: Treace Medical Concepts (NASDAQ:TMCI) & MiniMed Group (NASDAQ:MMED)September 27, 2026 | americanbankingnews.comThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.October 5 at 1:00 AM | Banyan Hill Publishing (Ad)Did Treace Medical Concepts, Inc. Insiders Breach their Fiduciary Duties to Shareholders?September 25, 2026 | prnewswire.comCritical Comparison: Treace Medical Concepts (NASDAQ:TMCI) versus TransMedics Group (NASDAQ:TMDX)September 24, 2026 | americanbankingnews.comTreace Medical (TMCI) Reports Five-Year Bunion Results. Can Evidence Drive Adoption?September 22, 2026 | insidermonkey.comTreace Announces Results of Three Clinical Studies Including the Milestone 5-Year ALIGN3D(R) Study Demonstrating Sustained, Positive Outcomes of the Lapiplasty(R) ProcedureSeptember 18, 2026 | marketscreener.comMTreace Medical Concepts, Inc.: Treace Announces Results of Three Clinical Studies Including the Milestone 5-Year ALIGN3D Study Demonstrating Sustained, Positive Outcomes of the ...September 18, 2026 | finanznachrichten.deSee More Headlines TMCI Stock Analysis - Frequently Asked Questions How have TMCI shares performed this year? Treace Medical Concepts' stock was trading at $2.45 at the beginning of the year. Since then, TMCI shares have increased by 79.2% and is now trading at $4.39. How were Treace Medical Concepts' earnings last quarter? Treace Medical Concepts, Inc. (NASDAQ:TMCI) announced its earnings results on Friday, August, 7th. The company reported ($0.24) earnings per share for the quarter, topping analysts' consensus estimates of ($0.30) by $0.06. The business earned $45.38 million during the quarter, compared to analyst estimates of $44.02 million. Treace Medical Concepts had a negative trailing twelve-month return on equity of 71.37% and a negative net margin of 28.99%. Read the conference call transcript. When did Treace Medical Concepts IPO? Treace Medical Concepts (TMCI) raised $180 million in an initial public offering on Thursday, April 22nd 2021. The company issued 11,250,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and SVB Leerink and Stifel were co-managers. How do I buy shares of Treace Medical Concepts? Shares of TMCI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Treace Medical Concepts own? Based on aggregate information from My MarketBeat watchlists, some other companies that Treace Medical Concepts investors own include American Water Works (AWK), DiamondRock Hospitality (DRH), The RMR Group (RMR), Waste Connections (WCN), AUO (AUOTY), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM). Company Calendar Last Earnings8/07/2026Today10/05/2026Next Earnings (Estimated)11/05/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (5m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 TMCI's financial health is in the Green zone, according to TradeSmith. TMCI has been in this zone for over 5 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:TMCI CIK1630627 Webwww.treace.com Phone904-373-5940FaxN/AEmployees450Year FoundedN/APrice Target and Rating Average Price Target for Treace Medical Concepts$5.17 High Price Target$7.00 Low Price Target$3.00 Potential Upside/Downside+17.8%Consensus RatingReduce Rating Score (0-4)1.86 Research Coverage7 Analysts Profitability EPS (Trailing Twelve Months)($0.93) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$59 million Net Margins-28.99% Pretax Margin-28.99% Return on Equity-71.37% Return on Assets-30.49% Debt Debt-to-Equity Ratio0.83 Current Ratio2.90 Quick Ratio1.95 Sales & Book Value Annual Sales$212.69 million Price / Sales1.34 Cash FlowN/A Price / Cash FlowN/A Book Value$1.37 per share Price / Book3.20Miscellaneous Outstanding Shares65,040,000Free Float49,804,000Market Cap$285.53 million OptionableOptionable Beta1.48 The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (NASDAQ:TMCI) was last updated on 10/5/2026 by MarketBeat.com Staff. From Our PartnersThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredDOJ Admits It In Court—Your Cash Can Be Seized Without WarningThe Department of Justice recently argued in court that cash may not be legally your property - raising concer...Priority Gold | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Treace Medical Concepts, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Treace Medical Concepts With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
